Working Group Members
Cédric Brisson
iNovia Capital
Gilles Duruflé
Sylvain Gareau
Caisse de dépôt
et placement du Québec
Maha Katabi
Sectoral Asset
Management Inc.
Stephen Hurwitz
Choate, Hall & Stewart LLP
Jean-François Leprince
CTI Life Sciences
Last update : March 11, 2009
Working groups
The Funding Working Group
Mission
Face the challenges in stimulating funding of the sector;
Sharpen the sector’s profile so as to favour the inflow of capital and the creation of investment opportunities.
Challenges
Favour the emergence of an integrated funding ecosystem for companies at all stages of development;
Eliminate barriers to foreign investment caused by the current tax environment (Section 116);
Increase the size, improve the performance and ensure the refinancing of existing and new funds;
Encourage conditions favourable to partnership between the big pharmas and the biotechs;
Increase access to funding for research before the startup stage.
Projects
Source: Bilan des activités de Montréal InVivo pour la période du 1er janvier au 31 décembre 2007 (Summary of activities of Montréal InVivo for the period January 1 to December 31 2007)
Bio VentureForum East 2007
1st time outside the U.S.
A success with some 400 visitors
60 venture capital companies, of which 24 Canadian
Record number of CEO’s
In collaboration with BIOQuébec and BIOTECanada
Broad media coverage, including interviews (The Money Channel and Les Affaires.Télé)
Follow-up meetings
Production of reports
Public consultation on financial aid to regions of importance to the new economy; report presented to the Working group on fiscal aid to regions of importance to the new economy
TOP 10 regions offering incentives particular to the life sciences
Participation and collaboration in BIOQuébec’s Rendez-vous Capital 2007
Consultez notre groupe du LinkedIn